BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19430297)

  • 1. Noninvasive molecular detection of head and neck squamous cell carcinoma: an exploratory analysis.
    Sethi S; Benninger MS; Lu M; Havard S; Worsham MJ
    Diagn Mol Pathol; 2009 Jun; 18(2):81-7. PubMed ID: 19430297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
    Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
    Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma.
    Cao Y; Green K; Quattlebaum S; Milam B; Lu L; Gao D; He H; Li N; Gao L; Hall F; Whinery M; Handley E; Ma Y; Xu T; Jin F; Xiao J; Wei M; Smith D; Bornstein S; Gross N; Pyeon D; Song J; Lu SL
    Clin Epigenetics; 2018; 10():43. PubMed ID: 29636832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse.
    Lallemant B; Evrard A; Combescure C; Chapuis H; Chambon G; Raynal C; Reynaud C; Sabra O; Joubert D; Hollande F; Lallemant JG; Lumbroso S; Brouillet JP
    BMC Cancer; 2009 Oct; 9():370. PubMed ID: 19835631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.
    Lim Y; Sun CX; Tran P; Punyadeera C
    Biomark Med; 2016; 10(3):301-13. PubMed ID: 26888346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary markers and risk factor data: a multivariate modeling approach for head and neck squamous cell carcinoma detection.
    Pereira LH; Adebisi IN; Perez A; Wiebel M; Reis I; Duncan R; Goodwin WJ; Hu JJ; Lokeshwar VB; Franzmann EJ
    Cancer Biomark; 2011; 10(5):241-9. PubMed ID: 22699785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.
    Demokan S; Chang X; Chuang A; Mydlarz WK; Kaur J; Huang P; Khan Z; Khan T; Ostrow KL; Brait M; Hoque MO; Liegeois NJ; Sidransky D; Koch W; Califano JA
    Int J Cancer; 2010 Nov; 127(10):2351-9. PubMed ID: 20162572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum protein profile analysis in patients with head and neck squamous cell carcinoma.
    Gourin CG; Xia ZS; Han Y; French AM; O'Rourke AK; Terris DJ; Adam BL
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):390-7. PubMed ID: 16618908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
    Gollin SM
    Genes Chromosomes Cancer; 2014 Dec; 53(12):972-90. PubMed ID: 25183546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
    Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
    Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis.
    Spafford MF; Koch WM; Reed AL; Califano JA; Xu LH; Eisenberger CF; Yip L; Leong PL; Wu L; Liu SX; Jerónimo C; Westra WH; Sidransky D
    Clin Cancer Res; 2001 Mar; 7(3):607-12. PubMed ID: 11297256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
    Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
    Al-Amri AM; Vatte C; Cyrus C; Chathoth S; Hashim TM; Mohamed YS; Al Ali R; Alsaid A; Al Ali A
    Cancer Biomark; 2016; 16(3):377-83. PubMed ID: 26889984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
    BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
    Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
    Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of head and neck squamous cell cancer biomarkers.
    Polanska H; Raudenska M; Gumulec J; Sztalmachova M; Adam V; Kizek R; Masarik M
    Oral Oncol; 2014 Mar; 50(3):168-77. PubMed ID: 24382422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.